Revvity RVTY Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Segment revenue by Business | ||||||
| Diagnostics | $349.27M+7.7% | $390.07M+10.0% | $356.13M+3.2% | $354.39M+3.3% | $324.37M+3.5% | |
| Life Sciences | $361.85M+6.3% | $381.99M+1.9% | $342.82M+1.2% | $365.9M+5.0% | $340.4M+1.2% | |
| Segment revenue by Geography | ||||||
| Americas | $315.99M+3.7% | $320.48M+0.6% | $307.28M+1.6% | $323.58M+5.1% | $304.63M+3.5% | |
| Asia | $172.08M-3.5% | $214.42M+0.5% | $189.28M-5.2% | $193.07M-3.1% | $178.34M+0.8% | |
| Europe | $223.05M+22.7% | $237.16M+20.1% | $202.4M+11.2% | $203.63M+10.3% | $181.79M+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Revvity break its business down?
- Revvity (RVTY) reports segment revenue by business across 2 parts — Diagnostics and Life Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Revvity's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Revvity's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
